Gene	Mutation	ProtMut	MutReads	WTReads	VAF	Info
ASXL1	chr20:32366465-32367727_Del:AGA	S47_Del:R	3	76	0.038	Neutral
CBL	chr11:119274894-119274894_Ins:T	L272fs*3	9	44	0.170	Sequencing_artefact
CSF3R	chr1:36467309-36467311_Del:CTG	R653-K654_Del:NR	39	455	0.079	Neutral
DNMT3A	chr2:25235821-25235825_Del:CTGAA	F827fs*25	6	118	0.048	Oncogenic
ETV6	chr12:11650159-11752450_Del:AGC	E12_Del:Q	8	82	0.089	Neutral
ETV6	chr12:11853484-11853484_Ins:T	S131fs*22	4	119	0.033	Sequencing_artefact
EZH2	chr7:148811685-148811685_Sub:C>T	W629*	3	53	0.054	Neutral
FLT3	chr13:28014452-28015701_ITD	A952-M953_Ins:ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA	9	342	0.026	Oncogenic
FLT3	chr13:28023477-28028287_ITD	E762-D763_Ins:EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKEHNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSE	7	254	0.027	Oncogenic
FLT3	chr13:28050157-28050157_Sub:G>A	T227M	266	1	0.996	Neutral
GNAS	chr20:58898985-58898985_Ins:GCA	G728-E729_Ins:S	18	90	0.167	Neutral
IDH1	chr2:208251539-208251539_Ins:T	I5fs*12	6	214	0.027	Sequencing_artefact
JAK2	chr9:5069060-5069060_Ins:A	N457fs*1	6	56	0.097	Sequencing_artefact
KIT	chr4:54699764-54699764_Ins:CAG	Q251-T252_Ins:Q	28	374	0.070	Neutral
KIT	chr4:54729384-54729384_Ins:T	L682fs*5	11	271	0.039	Sequencing_artefact
KIT	chr4:54729485-54731329_Del:GCA	D715_Del:S	118	218	0.351	Neutral
KMT2A	chr11:118474240-118474240_Ins:A	A1030fs*8	3	36	0.077	Sequencing_artefact
KMT2A	chr11:118491308-118491316_Del:AGGTACAGA	T1604-D1606_Del:GTE	9	2	0.818	Neutral
MPL	chr1:43338136-43338136_Sub:G>T	K39N	8	16	0.333	Neutral
NPM1	chr5:171392817-171392817_Ins:A	V156fs*5	172	4204	0.039	Sequencing_artefact
NPM1	chr5:171392914-171392914_Ins:A	V156fs*5	252	4279	0.056	Sequencing_artefact
NRAS	chr1:114708595-114708595_Ins:T	K170fs*5	3	133	0.022	Sequencing_artefact
PHF6	chrX:134393951-134393951_Ins:AGC	A139-D140_Ins:A	15	44	0.254	Neutral
RUNX1-RUNX1T1	RUNX1-RUNX1T1_chr21-chr8_PE	PE	43	321_132	NA	Oncogenic
RUNX1-RUNX1T1	RUNX1:chr21:34859474-RUNX1T1:chr8:92017363	RUNX1.R204-RUNX1T1.R90	22	75-11	NA	Oncogenic
SF3B1	chr2:197401451-197401451_Ins:A	F815fs*1	49	305	0.138	Sequencing_artefact
SF3B1	chr2:197416765-197416765_Ins:TT	K214fs*17	6	261	0.022	Sequencing_artefact
SF3B1	chr2:197416765-197416765_Ins:T	K214fs*20	40	261	0.133	Sequencing_artefact
STAG2	chrX:124025890-124025890_Sub:G>A	G32E	9	170	0.050	Neutral
STAG2	chrX:124025891-124025891_Ins:A	N34fs*10	8	168	0.045	Sequencing_artefact
STAG2	chrX:124030966-124030966_Sub:T>A	C43*	5	148	0.033	Neutral
STAG2	chrX:124030967-124030967_Ins:A	G46fs*40	9	149	0.057	Sequencing_artefact
STAG2	chrX:124057955-124057955_Ins:T	F468fs*4	8	191	0.040	Sequencing_artefact
STAG2	chrX:124086710-124086710_Ins:A	S1075fs*11	4	195	0.020	Sequencing_artefact
TET2	chr4:105275794-105275794_Sub:A>G	I1762V	18	11	0.621	Neutral
TP53	chr17:7676154-7676154_Sub:G>C	P72R	63	79	0.444	Neutral
U2AF1	chr21:43095697-43095697_Ins:A	F82fs*1	5	116	0.041	Sequencing_artefact
WT1	chr11:32389178-32391978_Del:ACTTGTTTT	T476-E478_Del:KTS	5	0	1.000	Neutral
ZRSR2	chrX:15803689-15803689_Sub:C>G	Q69E	12	27	0.308	Neutral
ZRSR2	chrX:15804132-15804132_Sub:G>A	E112K	5	33	0.132	Neutral
ZRSR2	chrX:15808271-15808271_Sub:G>T	E146D	3	32	0.086	Neutral